Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA) CEO and managing director David Foster to get the short end of the long story on the company’s latest news.
Hosted on MSN1d
Island Pharmaceuticals starts phase 2b dengue trialIsland Pharmaceuticals has commenced its phase 2b clinical trial of lead drug ISLA-101 – for potentially treating dengue ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Island Pharmaceuticals Ltd is set to hold an Extraordinary General Meeting on January 28, 2025, encouraging ...
Island Pharmaceuticals Ltd (AU:ILA) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...
Stockhead on MSN1d
Health Check: Which stock just dumped 19% on earnings downgrade?Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...
Island Pharmaceuticals Ltd (AU:ILA) has released an update. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback